ACTIVADOR TISULAR DEL PLASMINOGENO RECOMBINANTE PDF

Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Meztirisar Zulutaur
Country: Bhutan
Language: English (Spanish)
Genre: Finance
Published (Last): 10 May 2010
Pages: 29
PDF File Size: 7.5 Mb
ePub File Size: 3.23 Mb
ISBN: 291-2-32290-601-6
Downloads: 76930
Price: Free* [*Free Regsitration Required]
Uploader: Yozil

Si continua navegando, consideramos que acepta su uso. Continuing navigation will be considered as acceptance of this use. This item has received.

March Pages ee24 Pages There were no deaths or embolism.

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

You can change the settings or obtain more information activado clicking here. Four patients had intracranial haemorrhage grade I, without sequelae at de. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

Three patients received low molecular weight heparin prior to using rTPA. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Subscribe to our Newsletter. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns.

TOP 10 Related  GERFLOR ATTRACTION PDF

Subscriber If you already have your login data, please click here. Previous article Next article. SRJ is a prestige metric based on the idea that not all citations are the same.

Are you a health professional able to prescribe or dispense drugs? Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator.

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. The medical records of 8 newborn tisjlar reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them. In 4 patients complete resolution of the thrombus was achieved in a mean of 3.

The superior vena cava was the most frequent location, with a mean time of installation before recombinanet diagnosis of 12 days. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

Print Send to a friend Export reference Mendeley Statistics.

TOP 10 Related  EL CAMINO A LA REALIDAD PENROSE DESCARGAR PDF

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. The patients included 4 males with a mean weight of gr.

CiteScore measures average citations received per document published. The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns.

From Monday to Friday from recombinahte a. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters.

There was a problem providing the content you requested

They received between 1 to 5 cycles with rTPA. Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization. Nine issues are published each year, including mostly originals, reviews and consensus documents.